Lung Microbiome in Asthma : Current Perspectives
A growing body of evidence implicates the human microbiome as a potentially influential player actively engaged in shaping the pathogenetic processes underlying the endotypes and phenotypes of chronic respiratory diseases, particularly of the airways. In this article, we specifically review current evidence on the characteristics of lung microbiome, and specifically the bacteriome, the modes of interaction between lung microbiota and host immune system, the role of the "lung-gut axis", and the functional effects thereof on asthma pathogenesis. We also attempt to explore the possibilities of therapeutic manipulation of the microbiome, aiming at the establishment of asthma prevention strategies and the optimization of asthma treatment.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2019 |
---|---|
Erschienen: |
2019 |
Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
---|---|
Enthalten in: |
Journal of clinical medicine - 8(2019), 11 vom: 14. Nov. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Loverdos, Konstantinos [VerfasserIn] |
---|
Links: |
---|
Themen: |
Asthma |
---|
Anmerkungen: |
Date Revised 28.09.2020 published: Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3390/jcm8111967 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM303425636 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM303425636 | ||
003 | DE-627 | ||
005 | 20231225112812.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2019 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/jcm8111967 |2 doi | |
028 | 5 | 2 | |a pubmed24n1011.xml |
035 | |a (DE-627)NLM303425636 | ||
035 | |a (NLM)31739446 | ||
035 | |a (PII)E1967 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Loverdos, Konstantinos |e verfasserin |4 aut | |
245 | 1 | 0 | |a Lung Microbiome in Asthma |b Current Perspectives |
264 | 1 | |c 2019 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 28.09.2020 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a A growing body of evidence implicates the human microbiome as a potentially influential player actively engaged in shaping the pathogenetic processes underlying the endotypes and phenotypes of chronic respiratory diseases, particularly of the airways. In this article, we specifically review current evidence on the characteristics of lung microbiome, and specifically the bacteriome, the modes of interaction between lung microbiota and host immune system, the role of the "lung-gut axis", and the functional effects thereof on asthma pathogenesis. We also attempt to explore the possibilities of therapeutic manipulation of the microbiome, aiming at the establishment of asthma prevention strategies and the optimization of asthma treatment | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a asthma | |
650 | 4 | |a immune responses | |
650 | 4 | |a inflammation | |
650 | 4 | |a microbiome | |
650 | 4 | |a pathogenesis | |
700 | 1 | |a Bellos, Georgios |e verfasserin |4 aut | |
700 | 1 | |a Kokolatou, Louiza |e verfasserin |4 aut | |
700 | 1 | |a Vasileiadis, Ioannis |e verfasserin |4 aut | |
700 | 1 | |a Giamarellos, Evangelos |e verfasserin |4 aut | |
700 | 1 | |a Pecchiari, Matteo |e verfasserin |4 aut | |
700 | 1 | |a Koulouris, Nikolaos |e verfasserin |4 aut | |
700 | 1 | |a Koutsoukou, Antonia |e verfasserin |4 aut | |
700 | 1 | |a Rovina, Nikoletta |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of clinical medicine |d 2012 |g 8(2019), 11 vom: 14. Nov. |w (DE-627)NLM230666310 |x 2077-0383 |7 nnns |
773 | 1 | 8 | |g volume:8 |g year:2019 |g number:11 |g day:14 |g month:11 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/jcm8111967 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 8 |j 2019 |e 11 |b 14 |c 11 |